Please note

Due to the recent spike in Covid-19 cases, we are no longer able to entertain walk-in visits to our headquarters or any of our facilities.


Dexa Group has been built on continual innovation. For fifty years, we have researched, developed, and distributed outstanding drugs that have helped millions. Apart from industry-leading pharmaceutical formulations, we also work on other innovations, such as the development of herbal drugs and of new drug delivery systems. Our research has yielded dozens of popular products that are used and patented all over the world.

Dexa Laboratories of Biomolecular Sciences

Dexa Laboratories of Biomolecular Sciences (DLBS) is a group of research institutions for the discovery, development and production of pharmaceuticals, bio-pharmaceuticals, and nutraceuticals.

Since its inception in 2005, DLBS has helped research, extract, and utilise natural ingredients, principally as bioactive ingredients in modern herbal medicines. In fact, all modern herbal medicines produced by Dexa Group have been researched by DLBS at its facilities in Indonesia. DLBS leverages Indonesia’s rich biodiversity, extracting bioactive ingredients from many life forms and other organic substances.

DLBS is home to some of the world’s most talented scientists and pharmacists. It also collaborates with — and trains — farmers to produce high-quality, standardized, natural ingredients. In this way, it continues to add value to the local ecosystem.

DLBS research meets, and often exceeds, the highest standards of scientific rigour, and all its products are equipped with strong molecular and clinical evidence. The group frequently collaborates with partner research centres all over the world, including with highly-regarded institutions of excellence in dozens of countries around the world, including the United States, Singapore, and Indonesia.

“The establishment of DLBS is the realisation of my dream for this nation to become a major player in the research and development of new drugs. Through research, we must be able to extract materials from Indonesian soil, manage them into medicine dedicated to humanity, not only at the Indonesian level but also throughout the world.”


(Late) Dr. Rudy Soetikno
Lt. Col. (Retd.), Health and Medical Corps,Indonesian Armed Forces

Founder,Dexa Group

Partial list of DLBS products


DLBS 1033


DLBS 0533


DLBS 1442


DLBS 3233


DLBS 2411


DLBS 1442


DLBS 08E40


DLBS 5447

Vitafem Free Me

DLBS 1442

Dexa Development Center

The facility currently has a sterile manufacturing line for liquid injections and freeze dried injections in wide-range vial sizes, with variable batch size. The manufacturing line is capable of aseptic processing in a microbiologically controlled environment, as well as terminally sterilized oncology products. By implementing a safe and efficient manufacturing process, including a rigorous quality management system, Fonko has developed a reputation for providing oncology products of uncompromising quality.


Dexa Group’s state-of-the-art manufacturing and research facilities have been certified by many institutions. Some of these are listed below.

Ministry of Health


National Agency for Drug and Food Control


Medicines & Healthcare products Regulatory Agency

The United Kingdom

Department of Health


Trade Supervisory Authority

Lower Saxony, Germany

ISO 9001:2015

Bureau Veritas

HACCP (GMP) certification

Bureau Veritas

ISO 22000:2015

Bureau Veritas

National Agency for Food and Drug Administration and Control


Halal Assurance System

Majelis Ulama Indonesia